KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GoodRx Holdings (GDRX) Treasury Shares (2019 - 2025)

GoodRx Holdings (GDRX) has disclosed Treasury Shares for 7 consecutive years, with $25.2 million as the latest value for Q4 2025.

  • Quarterly Treasury Shares rose 12.67% to $25.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $25.2 million through Dec 2025, up 12.67% year-over-year, with the annual reading at $25.2 million for FY2025, 12.67% up from the prior year.
  • Treasury Shares hit $25.2 million in Q4 2025 for GoodRx Holdings, up from $20.0 million in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $25.2 million in Q4 2025 to a low of $939000.0 in Q2 2021.
  • Historically, Treasury Shares has averaged $10.9 million across 5 years, with a median of $7.8 million in 2021.
  • Biggest five-year swings in Treasury Shares: tumbled 87.63% in 2023 and later skyrocketed 1736.56% in 2024.
  • Year by year, Treasury Shares stood at $5.6 million in 2021, then skyrocketed by 49.8% to $8.5 million in 2022, then surged by 41.91% to $12.0 million in 2023, then surged by 86.41% to $22.4 million in 2024, then grew by 12.67% to $25.2 million in 2025.
  • Business Quant data shows Treasury Shares for GDRX at $25.2 million in Q4 2025, $20.0 million in Q3 2025, and $20.0 million in Q2 2025.